![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Neurodevelopmental and Respiratory Outcomes at 2 Years of Age in Preterm Infants Treated with Inhaled Nitric Oxide: the Euno Trial Follow Up
Background and aims: The EUNO trial of inhaled nitric oxide (iNO) for the prevention of BPD showed similar frequencies for the primary outcome (survival without BPD at 36 weeks postmenstrual age (PMA): iNO 65.3%;...
-
Article
731 Organisation of Paediatric Emergency Care in Europe
Paediatric Emergency Medicine (PEM) is a relatively new and rapidly evolving subspecialty, and in other parts of the world it is now established as a Board-certified paediatric subspecialty. In Europe, PEM has...
-
Article
910 Sensitivity and Specificity of the Rapid Influenza Antigen Test Clearview® Exact Influenza a and B for Pandemic Iunfluenza A/H1N1 (2009)
Reverse-transcriptase polymerase chain reaction (RT-PCR) is considered to be the reference test for diagnosis of influenza, because of its high sensitivity and specificity. Rapid Influenza Antigen Test (RIAT) ...
-
Article
240 Factors Influencing Neurological Outcome of Children with Bacterial Meningitis
Background and aims: Acute bacterial meningitis is a life-threatening illness with possible long-term neurocognitive sequelae. Aim of the study was to identify clinical and biological factors associated with d...
-
Article
Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure
Inhaled nitric oxide (iNO) has been shown to improve oxygenation in severe persistent pulmonary hypertension of the newborn (PPHN). However, PPHN is often associated with various lung diseases. Thus, response...
-
Article
RT-PA for Thrombotic Complications in 16 Neonates 78
-
Article
Hemodynamics and oxygenation changes induced by the discontinuation of low-dose inhalational nitric oxide in newborn infants
To assess changes associated with nitric oxide (NO) discontinuation in neonates receiving inhalational NO therapy as a treatment for pulmonary hypertension of the neonate (PPHN).